CBP/p300-IN-18 (compound 8) is a potent EP300/CBP HAT inhibitor with IC 50 s of 0.056, 0.46 µM for HAT EP300 and LK2 H3K27, respectively.
Products | Products > Disease Areas > Cancer | Products > Signaling Pathways > Epigenetics | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > Histone Acetyltransferase
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.